Licensing opportunities
The biopharmaceutical company Biovitrum of Stockholm, Sweden is restructuring its business and looking to out-license several early-stage research projects, primarily within diabetes and obesity. In total, ten projects are on offer at different stages preclinical development.
The company previously announced that it is looking for partners for two clinical Phase II projects, in neuropathic pain and glaucoma.
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
